PD-L1 >= 5%
About
Biomarker Type: Protein expression
Present: True
Marker: PD-L1
Unit: Tumor Proportion Score (TPS)
Equality: >=
Value: 0.05
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | PD-L1 >= 5% | Bladder Urothelial Carcinoma | Atezolizumab |